BRAIN Biotech AG (ETR:BNN)

BRAIN Biotech AG Statistics

Total Valuation

ETR:BNN has a market cap or net worth of EUR 51.12 million. The enterprise value is 45.98 million.

Market Cap	51.12M
Enterprise Value	45.98M

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

ETR:BNN has 21.85 million shares outstanding.

Current Share Class	21.85M
Shares Outstanding	21.85M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	11.87%
Float	9.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.04
PB Ratio	-70.22
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.33
EV / Sales	0.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.85

Financial Position

The company has a current ratio of 1.48

Current Ratio	1.48
Quick Ratio	0.29
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.92

Financial Efficiency

Return on equity (ROE) is -223.66% and return on invested capital (ROIC) is -90.92%.

Return on Equity (ROE)	-223.66%
Return on Assets (ROA)	-5.92%
Return on Invested Capital (ROIC)	-90.92%
Return on Capital Employed (ROCE)	-14.15%
Weighted Average Cost of Capital (WACC)	7.79%
Revenue Per Employee	167,842
Profits Per Employee	-36,377
Employee Count	292
Asset Turnover	0.67
Inventory Turnover	n/a

Taxes

Income Tax	-256,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.49% in the last 52 weeks. The beta is 0.64, so ETR:BNN's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	-4.49%
50-Day Moving Average	2.40
200-Day Moving Average	2.31
Relative Strength Index (RSI)	48.61
Average Volume (20 Days)	6,893

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:BNN had revenue of EUR 49.01 million and -10.62 million in losses. Loss per share was -0.49.

Revenue	49.01M
Gross Profit	28.26M
Operating Income	-6.97M
Pretax Income	-10.97M
Net Income	-10.62M
EBITDA	-3.57M
EBIT	-6.97M
Loss Per Share	-0.49

Balance Sheet

The company has 5.15 million in cash and n/a in debt, with a net cash position of 5.15 million or 0.24 per share.

Cash & Cash Equivalents	5.15M
Total Debt	n/a
Net Cash	5.15M
Net Cash Per Share	0.24
Equity (Book Value)	-728,000
Book Value Per Share	-0.03
Working Capital	8.40M

Cash Flow

In the last 12 months, operating cash flow was -7.96 million and capital expenditures -1.53 million, giving a free cash flow of -9.49 million.

Operating Cash Flow	-7.96M
Capital Expenditures	-1.53M
Free Cash Flow	-9.49M
FCF Per Share	-0.43

Margins

Gross margin is 57.66%, with operating and profit margins of -14.22% and -21.67%.

Gross Margin	57.66%
Operating Margin	-14.22%
Pretax Margin	-22.38%
Profit Margin	-21.67%
EBITDA Margin	-7.29%
EBIT Margin	-14.22%
FCF Margin	n/a

Dividends & Yields

ETR:BNN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-20.78%
FCF Yield	-18.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2